Scribd Logo
Upload

Welcome to Scribd!

  • 03 - 2021-01-26 CT Assignment

    Uploaded by

    Camilo Toro
    14 views1 page
    Pfizer Inc.'s total liabilities in 2019 were $104 billion, total equity was $63.4 billion, and sales were $51.7 billion. Net income increased to $16.3 billion in 2019 from $11.1 billion in 2018. The debt to equity ratio increased to 1.64 in 2019 from 1.5 in 2018, while return on equity improved to 0.26 in 2019 from 0.17 in 2018.

    Original Description:

    Copyright

    © © All Rights Reserved

    Available Formats

    XLSX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Pfizer Inc.'s total liabilities in 2019 were $104 billion, total equity was $63.4 billion, and sales were $51.7 billion. Net income increased to $16.3 billion in 2019 from $11.1 billion in 2018. The debt to equity ratio increased to 1.64 in 2019 from 1.5 in 2018, while return on equity improved to 0.26 in 2019 from 0.17 in 2018.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as xlsx, pdf, or txt
    14 views1 page

    03 - 2021-01-26 CT Assignment

    Uploaded by

    Camilo Toro
    Pfizer Inc.'s total liabilities in 2019 were $104 billion, total equity was $63.4 billion, and sales were $51.7 billion. Net income increased to $16.3 billion in 2019 from $11.1 billion in 2018. The debt to equity ratio increased to 1.64 in 2019 from 1.5 in 2018, while return on equity improved to 0.26 in 2019 from 0.17 in 2018.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as xlsx, pdf, or txt
    of 1

    Camilo Toro-Ramirez Jan 26 2021

    Assignment 1
    Pfizer Inc. (NYSE: PFE) 2019 2018 *in millions USD
    A. Total Liabilities 104,042 95,664 *
    B. Total Equity 63,447 63,758 *
    C. Sales 51,750 53,647 *
    D. COGS 10,219 11,248 *
    E. Net Income 16,273 11,153 *
    F. Cash & Cash Equivalents 1,305 1,139 *
    G. Short-term investments 8,525 17,694 *
    H. Current Liabilities 37,304 31,858 *
    I. Accounts Receivable 8,724 8,025 *
    J. Market Value per Share 37.31 43.65 At closing Dec 31 of fiscal year
    K. EPS 2.87 1.87

    RATIOS:
    Debt to Equity A/B 1.639825 1.500423
    Gross Margin C-D 41,531 42,399 *
    Return on Equity E/B 0.256482 0.174927
    Quick Ratio (F+G+I)/H 0.497373 0.843054
    Price to Earnings ratio J/K 13 23.34225

    You might also like